METTL14 benefits the mesenchymal stem cells in patients with steroid-associated osteonecrosis of the femoral head by regulating the m6A level of PTPN6.

Abstract

Imbalanced osteogenic/adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) is considered the core pathological characteristic of steroid-associated osteonecrosis of the femoral head (SONFH). N6-Methyladenosine (m6A) is the most common type of RNA modification in eukaryotic cells and participates in various physiological and pathological processes. However, the relationship between m6A modification and SONFH has not been reported. In the present study, we aimed to explore the roles of m6A modifications and methyltransferase METTL14 in SONFH. Our results showed that the m6A levels were down-regulated in femoral head tissues and BMSCs from SONFH patients, and this effect was attributed to the reduction of METTL14. Furthermore, METTL14 overexpression in BMSCs from SONFH patients enhanced cell proliferation and osteogenic differentiation. We further identified PTPN6 as the downstream target of METTL14 by mRNA sequencing. Mechanistically, METTL14 regulated PTPN6 expression by increasing PTPN6 mRNA stability in an m6A-dependent manner. Moreover, PTPN6 knockdown abrogated the beneficial effects of METTL14 overexpression on BMSCs. Additionally, we found that METTL14 activated the Wnt signaling pathway, and this effect was caused by the interaction of PTPN6 and GSK-3β. In conclusion, we elucidated the functional roles of METTL14 and m6A methylation in SONFH BMSCs and identified a novel RNA regulatory mechanism, providing a potential therapeutic target for SONFH.

• Authors: Cheng Cheng, Haoping Zhang, Jia Zheng, Yi Jin, Donghui Wang, Zhipeng Dai
• Journal: Aging (Aging (Albany NY)) Vol. 13 Issue 24 Pg. 25903-25919 (12 15 2021) ISSN: 1945-4589 [Electronic] United States
• PMID: 34910686 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Steroids
• N-methyladenosine
• METTL14 protein, human
• Methyltransferases
• Glycogen Synthase Kinase 3 beta
• PTPN6 protein, human
• Protein Tyrosine Phosphatase, Non-Receptor Type 6
• Adenosine

Topics

• Adenosine (analogs & derivatives, metabolism)
• Bone Marrow (metabolism)
• Cell Differentiation
• Cell Proliferation
• Femur Head (metabolism, physiology)
• Glycogen Synthase Kinase 3 beta (metabolism)
• Humans
• Mesenchymal Stem Cells (metabolism)
• Methyltransferases (genetics)
• Osteogenesis (drug effects)
• Osteonecrosis (chemically induced, genetics)
• Protein Tyrosine Phosphatase, Non-Receptor Type 6 (genetics)
• Steroids (adverse effects)